Edgewise downgraded yesterday at Scotiabank after CIRRUS-HCM readout
As previously reported yesterday, Scotiabank downgraded Edgewise Therapeutics (EWTX) to Sector Perform from Outperform with a price target of ...
Edgewise downside move a buying opportunity, says RBC Capital
RBC Capital analyst Leonid Timashev lowered the firm’s price target on Edgewise Therapeutics (EWTX) to $52 from $56 and keeps an Outperform ...
CRN4 年
Zscaler Buys Application Security Startup Edgewise Networks
Edgewise Networks will significantly improve the security of east-west communication by verifying the identity of application software, services and processes, Zscaler said. Zscaler has purchased ...
Business Wire1 个月
Edgewise Therapeutics to Present at the Leerink Partners Global Healthcare Conference on ...
BOULDER, Colo.--(BUSINESS WIRE)--Edgewise Therapeutics, Inc., (Nasdaq: EWTX), a leading muscle disease biopharmaceutical company, today announced that management will present at the Leerink ...